rs975508

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016529.6(ATP8A2):​c.3378-21083A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.409 in 151,940 control chromosomes in the GnomAD database, including 13,004 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 13004 hom., cov: 32)

Consequence

ATP8A2
NM_016529.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.516

Publications

9 publications found
Variant links:
Genes affected
ATP8A2 (HGNC:13533): (ATPase phospholipid transporting 8A2) The protein encoded by this gene is a member of the P4 ATPase family of proteins, which are thought to be involved in a process called lipid flipping, whereby phospholipids are translocated inwards from the exoplasmic leaflet to the cytosolic leaflet of the cell membrane, which aids in generating and maintaining asymmetry in membrane lipids. This protein is predicted to contain an E1 E2 ATPase, a haloacid dehalogenase-like hydrolase (HAD) domain, and multiple transmembrane domains. Associations between this protein and cell cycle control protein 50A are important for translocation of phosphatidylserine across membranes. Mutations in this gene have been associated with a syndrome (CAMRQ4) characterized by cerebellar ataxia and cognitive disabilities. In addition, a translocation breakpoint within this gene was observed in an individual with neurological dysfunction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
ATP8A2 Gene-Disease associations (from GenCC):
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • cerebellar ataxia, intellectual disability, and dysequilibrium
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.431 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016529.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8A2
NM_016529.6
MANE Select
c.3378-21083A>G
intron
N/ANP_057613.4
ATP8A2
NM_001411005.1
c.3303-21083A>G
intron
N/ANP_001397934.1
ATP8A2
NM_001313741.1
c.3183-21083A>G
intron
N/ANP_001300670.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP8A2
ENST00000381655.7
TSL:1 MANE Select
c.3378-21083A>G
intron
N/AENSP00000371070.2
ATP8A2
ENST00000281620.11
TSL:1
n.*3196-21083A>G
intron
N/AENSP00000281620.7
ATP8A2
ENST00000682472.1
c.3303-21083A>G
intron
N/AENSP00000508103.1

Frequencies

GnomAD3 genomes
AF:
0.409
AC:
62025
AN:
151822
Hom.:
12986
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.404
Gnomad AMI
AF:
0.534
Gnomad AMR
AF:
0.362
Gnomad ASJ
AF:
0.518
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.406
Gnomad FIN
AF:
0.391
Gnomad MID
AF:
0.459
Gnomad NFE
AF:
0.435
Gnomad OTH
AF:
0.416
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.409
AC:
62085
AN:
151940
Hom.:
13004
Cov.:
32
AF XY:
0.403
AC XY:
29949
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.405
AC:
16759
AN:
41416
American (AMR)
AF:
0.361
AC:
5506
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.518
AC:
1795
AN:
3466
East Asian (EAS)
AF:
0.175
AC:
904
AN:
5158
South Asian (SAS)
AF:
0.405
AC:
1948
AN:
4804
European-Finnish (FIN)
AF:
0.391
AC:
4130
AN:
10574
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.435
AC:
29531
AN:
67940
Other (OTH)
AF:
0.420
AC:
887
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1844
3688
5533
7377
9221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.427
Hom.:
59466
Bravo
AF:
0.402
Asia WGS
AF:
0.313
AC:
1093
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.2
DANN
Benign
0.29
PhyloP100
-0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs975508; hg19: chr13-26565586; API